Report From Persistence Market Research Inc, The Urinary Drainage Bags Market Expected To Grow At A Compound Annual Growth Rate Of 6.2% And Reach $ 3.9 Billion By 2033

Must Read

Urinary diseases are the third most common issue among seniors, thus creating an immense opportunity for growth in the urinary drainage bags market.

By 2033, the Urinary Drainage Bags Market is expected to reach US$ 3.9 Billion. The market growth is anticipated at a CAGR of 6.2% from 2022 to 2032, with revenues estimated at US$ 2.1 Billion in 2023.

The market in this country is projected to hold a substantial global portion with an absolute dollar opportunity of US$ 682 Million.

Market players are raising awareness of urinary bags through various marketing methods and programs. In Australia, healthcare professionals have inspired patients to obtain thorough evaluations on bladder-related diseases, with the Commonwealth’s Continence Care Management Services assisting. 

It has a continence helpline where individuals can speak with experts for advice on goods related to this topic.

As reported by the American Society of Nephrology, urological diseases have become a significant health concern for elderly individuals – accounting for almost half of all doctor visits. Ulcerative colitis and IBD have risen recently, particularly among mature adults.

In industrialised countries, various ailments frequently appear, with a higher prevalence observed in urban areas.

The United Nations statistics indicate that certain European countries, such as Sweden and Germany, have experienced a substantial rise in their elderly populations. 

Disposable urine drainage bags are preferred over traditional urinary bags to reduce the risk of infection transfer from a patient to a healthcare provider.

North America, which maintained a significant portion of the global market with an impressive 39% revenue share in 2020, is anticipated to witness a CAGR of 6% over the forecast period.

The continual rise in disorders such as UI, bladder obstruction, urine retention, Benign Prostate Hyperplasia (BPH), and bladder cancer is fueling the market’s growth. According to the American Academy of Family Physicians (AAFP), over 250,000 BPH patients receive surgery annually.

- Advertisement -spot_img
- Advertisement -spot_img
Latest News
- Advertisement -spot_img

More Articles Like This

- Advertisement -spot_img